Search results
Does Concert (CNCE) Have the Potential to Rally 158% as Wall Street Analysts Expect?
Zacks via Yahoo Finance· 2 years agoThe mean of analysts' price targets for Concert (CNCE) points to a 158.3% upside in the stock. While...
Recent Price Trend in Concert (CNCE) is Your Friend, Here's Why
Zacks via Yahoo Finance· 2 years agoConcert (CNCE) could be a solid choice for shorter-term investors looking to capitalize on the...
Here's Why Concert Pharmaceuticals (CNCE) is a Great Momentum Stock to Buy
Zacks via Yahoo Finance· 2 years agoMomentum investing revolves around the idea of following a stock's recent trend in either direction....
Concert (CNCE) Stock Up 17% Last Week on Sun Pharma Buyout Offer
Zacks via Yahoo Finance· 1 year agoConcert Pharmaceuticals (CNCE) enters into a definitive agreement to be acquired by India-based Sun...
Concert Pharmaceuticals (CNCE) Reports Q3 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 2 years agoConcert (CNCE) delivered earnings and revenue surprises of 1.69% and 97.58%, respectively, for the...
With 66% ownership in Concert Pharmaceuticals, Inc. (NASDAQ:CNCE), institutional investors have a...
Simply Wall St. via Yahoo Finance· 1 year agoIf you want to know who really controls Concert Pharmaceuticals, Inc. (NASDAQ:CNCE), then you'll...
Concert Pharmaceuticals (NASDAQ:CNCE) shareholders have endured a 65% loss from investing in the...
Simply Wall St. via Yahoo Finance· 2 years agoIt is doubtless a positive to see that the Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) share price...
What Is The Ownership Structure Like For Concert Pharmaceuticals, Inc. (NASDAQ:CNCE)?
Simply Wall St. via Yahoo Finance· 2 years agoIf you want to know who really controls Concert Pharmaceuticals, Inc. (NASDAQ:CNCE), then you'll...
We're Keeping An Eye On Concert Pharmaceuticals' (NASDAQ:CNCE) Cash Burn Rate
Simply Wall St. via Yahoo Finance· 1 year agoWe can readily understand why investors are attracted to unprofitable companies. Indeed, Concert...
Trade Alert: The Co-Founder & Independent Chairman of the Board Of Concert Pharmaceuticals, Inc....
Simply Wall St. via Yahoo Finance· 2 years agoConcert Pharmaceuticals, Inc. (NASDAQ:CNCE) shareholders (or potential shareholders) will be happy...